Published in BMC Cancer on November 06, 2002
Calcium-dependent and -independent interactions of the S100 protein family. Biochem J (2006) 2.62
Psoriasin (S100A7) is significantly up-regulated in human epithelial skin tumours. J Cancer Res Clin Oncol (2006) 1.15
S100A7 and the progression of breast cancer. Breast Cancer Res (2004) 1.14
A network-based, integrative study to identify core biological pathways that drive breast cancer clinical subtypes. Br J Cancer (2012) 1.05
RanBPM associates with CD39 and modulates ecto-nucleotidase activity. Biochem J (2006) 1.05
Stability and function of mammalian lethal giant larvae-1 oncoprotein are regulated by the scaffolding protein RanBPM. J Biol Chem (2010) 0.89
RAN-binding protein 9 is involved in alternative splicing and is critical for male germ cell development and male fertility. PLoS Genet (2014) 0.82
Mechanistic attributes of S100A7 (psoriasin) in resistance of anoikis resulting tumor progression in squamous cell carcinoma of the oral cavity. Cancer Cell Int (2015) 0.79
RanBPM protein acts as a negative regulator of BLT2 receptor to attenuate BLT2-mediated cell motility. J Biol Chem (2013) 0.76
Structural and functional characterization of a triple mutant form of S100A7 defective for Jab1 binding. Protein Sci (2009) 0.76
Interaction with adipocyte stromal cells induces breast cancer malignancy via S100A7 upregulation in breast cancer microenvironment. Breast Cancer Res (2017) 0.75
RanBP9/TSSC3 complex cooperates to suppress anoikis resistance and metastasis via inhibiting Src-mediated Akt signaling in osteosarcoma. Cell Death Dis (2016) 0.75
A new variant of glycoprotein CD44 confers metastatic potential to rat carcinoma cells. Cell (1991) 7.29
S100: a multigenic family of calcium-modulated proteins of the EF-hand type with intracellular and extracellular functional roles. Int J Biochem Cell Biol (2001) 5.29
The S100 family of EF-hand calcium-binding proteins: functions and pathology. Trends Biochem Sci (1996) 4.63
Nuclear protein import. Curr Opin Cell Biol (1997) 2.44
Molecular cloning, occurrence, and expression of a novel partially secreted protein "psoriasin" that is highly up-regulated in psoriatic skin. J Invest Dermatol (1991) 1.99
When overexpressed, a novel centrosomal protein, RanBPM, causes ectopic microtubule nucleation similar to gamma-tubulin. J Cell Biol (1998) 1.78
Ran and nuclear transport. J Biol Chem (1998) 1.67
Psoriasin: a novel chemotactic protein. J Invest Dermatol (1996) 1.59
Psoriasin (S100A7) expression and invasive breast cancer. Am J Pathol (1999) 1.56
New perspectives on S100 proteins: a multi-functional Ca(2+)-, Zn(2+)- and Cu(2+)-binding protein family. Biometals (1998) 1.50
Human IP-10 selectively promotes dominance of polyclonally activated and environmental antigen-driven IFN-gamma over IL-4 responses. FASEB J (1998) 1.45
Bladder squamous cell carcinomas express psoriasin and externalize it to the urine. J Urol (1996) 1.42
Microdissection RT-PCR analysis of gene expression in pathologically defined frozen tissue sections. Biotechniques (1996) 1.39
Differential expression of psoriasin messenger RNA between in situ and invasive human breast carcinoma. Cancer Res (1996) 1.31
S100A7, S100A10, and S100A11 are transglutaminase substrates. Biochemistry (2001) 1.08
Translocation of profilaggrin N-terminal domain into keratinocyte nuclei with fragmented DNA in normal human skin and loricrin keratoderma. Lab Invest (1998) 1.01
Probable interaction between S100A7 and E-FABP in the cytosol of human keratinocytes from psoriatic scales. Mol Cell Biochem (1999) 0.84
Immunohistochemical and molecular characterization of cultured keratinocytes after dispase-mediated detachment from the growth substratum. Exp Dermatol (2000) 0.84
Heat shock modulates the expression of the metastasis associated gene MTS1 and proliferation of murine and human cancer cells. DNA Cell Biol (1998) 0.83
Effects of overexpression of Ran/TC4 mammalian cells in vitro. Exp Cell Res (1998) 0.82
Frequent somatic mutations in PTEN and TP53 are mutually exclusive in the stroma of breast carcinomas. Nat Genet (2002) 3.89
Mammographic density is related to stroma and stromal proteoglycan expression. Breast Cancer Res (2003) 2.37
Systematic analysis of immune infiltrates in high-grade serous ovarian cancer reveals CD20, FoxP3 and TIA-1 as positive prognostic factors. PLoS One (2009) 2.36
Tumor-infiltrating lymphocytes predict response to anthracycline-based chemotherapy in estrogen receptor-negative breast cancer. Breast Cancer Res (2011) 2.25
The Prohibitins: emerging roles in diverse functions. J Cell Mol Med (2006) 1.81
The autophagy protein LC3A correlates with hypoxia and is a prognostic marker of patient survival in clear cell ovarian cancer. J Pathol (2012) 1.72
Activated mitogen-activated protein kinase expression during human breast tumorigenesis and breast cancer progression. Clin Cancer Res (2002) 1.71
Reduced expression of the small leucine-rich proteoglycans, lumican, and decorin is associated with poor outcome in node-negative invasive breast cancer. Clin Cancer Res (2003) 1.67
CD20+ tumor-infiltrating lymphocytes have an atypical CD27- memory phenotype and together with CD8+ T cells promote favorable prognosis in ovarian cancer. Clin Cancer Res (2012) 1.64
Prohibitin: a potential target for new therapeutics. Trends Mol Med (2005) 1.60
Matrix metalloproteinase-9 deficiency results in enhanced allergen-induced airway inflammation. J Immunol (2004) 1.49
Targeting the EGFR pathway for cancer therapy. Curr Med Chem (2006) 1.48
S100 proteins and their influence on pro-survival pathways in cancer. Biochem Cell Biol (2004) 1.37
Clinical significance of estrogen receptor phosphorylation. Endocr Relat Cancer (2011) 1.33
Psoriasin (S100A7) expression is associated with poor outcome in estrogen receptor-negative invasive breast cancer. Clin Cancer Res (2003) 1.23
Psoriasin interacts with Jab1 and influences breast cancer progression. Cancer Res (2003) 1.20
Surveillance of the tumor mutanome by T cells during progression from primary to recurrent ovarian cancer. Clin Cancer Res (2013) 1.18
BRCA1 and c-Myc associate to transcriptionally repress psoriasin, a DNA damage-inducible gene. Cancer Res (2005) 1.15
Influence of evolution in tumor biobanking on the interpretation of translational research. Cancer Epidemiol Biomarkers Prev (2008) 1.15
Clonal evolution of high-grade serous ovarian carcinoma from primary to recurrent disease. J Pathol (2012) 1.15
The S100A7-c-Jun activation domain binding protein 1 pathway enhances prosurvival pathways in breast cancer. Cancer Res (2005) 1.15
Tumor-infiltrating T cells correlate with NY-ESO-1-specific autoantibodies in ovarian cancer. PLoS One (2008) 1.14
S100A7 and the progression of breast cancer. Breast Cancer Res (2004) 1.14
Necrosis and hypoxia in invasive breast carcinoma. Breast Cancer Res Treat (2003) 1.12
Tumor cell expression of HLA-DM associates with a Th1 profile and predicts improved survival in breast carcinoma patients. Int Immunol (2006) 1.11
Identification of a novel breast- and salivary gland-specific, mucin-like gene strongly expressed in normal and tumor human mammary epithelium. Cancer Res (2002) 1.10
The hypoxia-regulated transcription factor DEC1 (Stra13, SHARP-2) and its expression in human tissues and tumours. J Pathol (2004) 1.08
Increasing the relative expression of endogenous non-coding Steroid Receptor RNA Activator (SRA) in human breast cancer cells using modified oligonucleotides. Nucleic Acids Res (2009) 1.07
Psoriasin (S100A7) expression is altered during skin tumorigenesis. BMC Dermatol (2003) 1.06
Estrogen receptor-alpha phosphorylated at Ser118 is present at the promoters of estrogen-regulated genes and is not altered due to HER-2 overexpression. Cancer Res (2006) 1.05
S100A7 (psoriasin) expression is associated with aggressive features and alteration of Jab1 in ductal carcinoma in situ of the breast. Breast Cancer Res (2004) 1.04
Identification of new human coding steroid receptor RNA activator isoforms. Biochem Biophys Res Commun (2003) 1.04
Allergic humans are hyporesponsive to a CXCR3 ligand-mediated Th1 immunity-promoting loop. FASEB J (2003) 1.04
Immunohistochemical validation of multiple phospho-specific epitopes for estrogen receptor alpha (ERalpha) in tissue microarrays of ERalpha positive human breast carcinomas. Breast Cancer Res Treat (2008) 1.03
Intermittent hypoxia induces proteasome-dependent down-regulation of estrogen receptor alpha in human breast carcinoma. Clin Cancer Res (2004) 1.03
Permission to contact (PTC)--a strategy to enhance patient engagement in translational research. Biopreserv Biobank (2013) 1.03
Lower cortisol levels in children with asthma exposed to recurrent maternal distress from birth. J Allergy Clin Immunol (2009) 1.02
Analysis of gene expression in ductal carcinoma in situ of the breast. Clin Cancer Res (2002) 1.01
Is oestrogen receptor-beta a predictor of endocrine therapy responsiveness in human breast cancer? Endocr Relat Cancer (2006) 0.98
Selective immune redirection in humans with ragweed allergy by injecting Amb a 1 linked to immunostimulatory DNA. J Allergy Clin Immunol (2004) 0.98
Estrogen receptor alpha negative breast cancer patients: estrogen receptor beta as a therapeutic target. J Steroid Biochem Mol Biol (2007) 0.98
Timing of consent for the research use of surgically removed tissue: is postoperative consenting acceptable? Cancer (2009) 0.97
Claudins 1, 3, and 4 protein expression in ER negative breast cancer correlates with markers of the basal phenotype. Virchows Arch (2009) 0.96
Ultrasensitive ELISA for measurement of human cytokine responses in primary culture. Methods Mol Med (2008) 0.95
Biospecimen use correlates with emerging techniques in cancer research: impact on planning future biobanks. Biopreserv Biobank (2012) 0.95
FDC-SP, a novel secreted protein expressed by follicular dendritic cells. J Immunol (2002) 0.94
Estrogen receptor-beta regulates psoriasin (S100A7) in human breast cancer. Breast Cancer Res Treat (2006) 0.94
Impact of a Permission to Contact (PTC) platform on biobank enrollment and efficiency. Biopreserv Biobank (2013) 0.93
Validation of urinary CXCL10 as a marker of borderline, subclinical, and clinical tubulitis. Transplantation (2011) 0.93
Expression analysis of the mouse S100A7/psoriasin gene in skin inflammation and mammary tumorigenesis. BMC Cancer (2005) 0.92
A phosphorylation code for oestrogen receptor-alpha predicts clinical outcome to endocrine therapy in breast cancer. Endocr Relat Cancer (2010) 0.92
The relevance of phosphorylated forms of estrogen receptor in human breast cancer in vivo. J Steroid Biochem Mol Biol (2009) 0.91
Differential expression of claudin 1, 3, and 4 during normal mammary gland development in the mouse. DNA Cell Biol (2006) 0.90
Spontaneous mammary tumors differ widely in their inherent sensitivity to adoptively transferred T cells. Cancer Res (2007) 0.90
Assessment of multiple different estrogen receptor-beta antibodies for their ability to immunoprecipitate under chromatin immunoprecipitation conditions. Breast Cancer Res Treat (2006) 0.90
Highly homologous hS100A15 and hS100A7 proteins are distinctly expressed in normal breast tissue and breast cancer. Cancer Lett (2009) 0.89
What are the biggest challenges and opportunities for biorepositories in the next three to five years? Biopreserv Biobank (2010) 0.89
Novel recombinant interleukin-13 peptide-based vaccine reduces airway allergic inflammatory responses in mice. Am J Respir Crit Care Med (2007) 0.89
A bi-faceted role of estrogen receptor β in breast cancer. Endocr Relat Cancer (2013) 0.89
Relationship between mammaglobin expression and estrogen receptor status in breast tumors. Endocrine (2003) 0.88
Steroid Receptor RNA Activator Protein (SRAP): a potential new prognostic marker for estrogen receptor-positive/node-negative/younger breast cancer patients. Breast Cancer Res (2009) 0.88
Certification for biobanks: the program developed by the Canadian Tumour Repository Network (CTRNet). Biopreserv Biobank (2012) 0.88
Biospecimen use in cancer research over two decades. Biopreserv Biobank (2010) 0.88
Regulation of the high affinity IgE receptor (Fc epsilonRI) in human neutrophils: role of seasonal allergen exposure and Th-2 cytokines. PLoS One (2008) 0.87
TLR4 Asp299Gly and Thr399Ile polymorphisms: no impact on human immune responsiveness to LPS or respiratory syncytial virus. PLoS One (2010) 0.87
Human subjects without peanut allergy demonstrate T cell-dependent, TH2-biased, peanut-specific cytokine and chemokine responses independent of TH1 expression. J Allergy Clin Immunol (2006) 0.87
Reactive oxygen species induce phosphorylation of serine 118 and 167 on estrogen receptor alpha. Breast Cancer Res Treat (2008) 0.87
Differential expression and comparative subcellular localization of estrogen receptor beta isoforms in virally transformed and normal cultured human lens epithelial cells. Exp Eye Res (2005) 0.87
Sustained suppression of IL-13 by a vaccine attenuates airway inflammation and remodeling in mice. Am J Respir Cell Mol Biol (2013) 0.87
Estrogen receptors inhibit Smad3 transcriptional activity through Ap-1 transcription factors. Mol Cell Biochem (2007) 0.86
Oncostatin M suppresses oestrogen receptor-α expression and is associated with poor outcome in human breast cancer. Endocr Relat Cancer (2012) 0.86
Endogenous IFN-gamma and IL-18 production directly limit induction of type 2 immunity in vivo. Eur J Immunol (2002) 0.86
Human metapneumovirus elicits weak IFN-gamma memory responses compared with respiratory syncytial virus. J Immunol (2006) 0.86